Super high-flux dialysis for restless legs syndrome
Part of Brain & nervous system, Kidney & urinary, Mental health, Women’s health & pregnancy clinical trials.
This trial tests whether a special type of dialysis, called super high-flux hemodialysis, can improve symptoms of restless legs syndrome (RLS) in people already on maintenance dialysis. If you have RLS and meet the criteria, this treatment might help reduce your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with restless legs syndrome (RLS).
- You are at least 20 years old.
- You have been on high-flux hemodialysis for at least 3 months.
- You have a stable vascular access, like an AV fistula or graft.
- Your dialysis is adequate, with a URR of 65% or more or a Kt/V of 1.2 or more.
- You have enough iron in your blood, with ferritin at least 200 ng/mL and TSAT at least 20%.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a relaxation technique called autogenic training (a type of self-guided relaxation) can help people on dialysis feel better. It focuses on stress reduction, which may improve your overall well-being.
This study tests whether a spinal cord stimulator (a device that sends mild electrical pulses to the spinal cord) can help reduce severe restless legs syndrome (RLS) symptoms that have not improved with medication. If you have severe RLS, this could be a new way to find relief.
This study tests a device that sends mild electrical signals to the spinal cord to see if it can reduce severe restless legs syndrome symptoms when standard medicines haven't helped enough.
This study tests whether acupressure, a type of gentle pressure on specific body points, can help reduce restless legs syndrome and itching in people who are on dialysis. If it works, it could offer a drug-free way to feel more comfortable.
This trial tests a special dialysis filter (Elisio HX) that removes more waste products from the blood. It aims to see if this approach improves health outcomes for people on regular in-center hemodialysis.
This trial tests if dipyridamole, a medication that affects blood flow, can help relieve restless legs syndrome (RLS) in people on hemodialysis. It may offer a new treatment option for RS related to kidney failure.
Hear when a new End Stage Renal Failure, Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.